Home » Authors » James Etheridge

Articles by James Etheridge

Nokad Obtains Its First Functional KOs in Rats

April 11, 2007

By James Etheridge

Nokad Obtains Its First Functional KOs in Rats

April 11, 2007

By James Etheridge

Pfizer Initiates Development Of NicOx Glaucoma Drug Candidate

April 4, 2007

By James Etheridge

MilleGen and LFB Partner On New Generation of MAbs

April 4, 2007

By James Etheridge

Pfizer Initiates Development Of NicOx Glaucoma Drug Candidate

April 4, 2007

By James Etheridge

BioAlliance, Spepharm Partner In Deal To Market Loramyc

March 14, 2007

By James Etheridge

Transgene Reports Net '06 Loss But Expects Busy Year Ahead

March 14, 2007

By James Etheridge

BioAlliance, Spepharm Partner In Deal To Market Loramyc

March 14, 2007

By James Etheridge

Transgene Reports Net '06 Loss But Expects Busy Year Ahead

March 14, 2007

By James Etheridge

Celogos Receives €2.5M For Development of Cell Therapies

March 7, 2007

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 11, 2024.
Boryung invests $10M in Intuitive Machines for outer space R&D
BioWorld
Following its $60 million investment in Axiom Space Inc. last year, Boryung Co. Ltd. made a $10 million private placement in Intuitive Machines Inc. to grow its...
Phase II Huntington’s tie-up with Novartis could edge $3B for PTC
BioWorld
PTC Therapeutics Inc. said a “highly competitive process with several parties involved” led to the deal centered on the firm’s Huntington’s disease program with...
Elevar nabs Relay’s FGFR2 rare cancer drug in $500M deal
BioWorld
Elevar Therapeutics Inc. will license Relay Therapeutics Inc.’s “NDA-ready” bile duct cancer therapy, lirafugratinib (RLY-4008), through a potential $500 million...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.